Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Elizabeth Hoge currently holds 33,662.22 shares of Cartesian Therapeutics, Inc. (RNAC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Elizabeth Hoge has been a net neutral trader of RNAC stock. They have purchased $0 and sold $0 worth of shares.
Elizabeth Hoge's most recent insider trade was on Apr 2, 2026, when they sold 22,740.03 shares at $0.00 per share.
Elizabeth Hoge serves as Executive at Cartesian Therapeutics, Inc. (RNAC). They have executed 2 insider transactions totaling $0 over their tenure at the company.
Elizabeth Hoge holds the position of Executive at Cartesian Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Elizabeth Hoge has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Elizabeth Hoge was on Apr 2, 2026, when they sold $0 worth of RNAC shares. This transaction involved 22,740.03 shares at N/A per share.
Elizabeth Hoge currently owns 33,662.22 shares of Cartesian Therapeutics, Inc. (RNAC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Elizabeth Hoge's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Elizabeth Hoge has 2 Form 4 filings on record as an insider at Cartesian Therapeutics, Inc..
Set alerts for Elizabeth Hoge and 40,000+ other insiders.